baber/WOPTO huggingface dataset:
Patent FI-915439-A0 (FI)
Inventor: MCKINNEY LARRY S
IPC: H03C3/00
Filed: 1991-11-18
Abstract: An apparatus and method is disclosed which phase locks a frequency-agile modulated output signal to any selected channel of a comb generated output. The phase error of an input signal is tracked, the input signal is modulated up to a carrier output frequency, and the modulated output frequency is locked to the comb generator output by subtracting the input signal and negating the phase error.
Patent FI-941371-A0 (FI)
Inventor: ERIKSSON TORE
IPC: B05D3/00
Filed: 1994-03-24
Abstract: PCT No. PCT/SE92/00612 Sec. 371 Date Mar. 18, 1994 Sec. 102(e) Date Mar. 18, 1994 PCT Filed Sep. 4, 1992 PCT Pub. No. WO93/05887 PCT Pub. Date Apr. 1, 1993.An apparatus for blade coating of a travelling web, preferably a paper web, comprising means for supporting and feeding of the web and a doctor blade extending across the web and engaging the web along a first long-side thereof for evening out a coating composition applied to the web and a blade holder carrying the blade along a second long-side, characterized by pressure means arranged to bring, by applying pressure from an outer side of the blade and adjacent to the first long-side, the first long-side of the blade to engagement on the web without imparting substantial bending to the blade as seen in its cross section, said blade being movably clamped in the blade holder; a process for evening the coating of such a traveling web using such an apparatus.
Patent FI-943941-A0 (FI)
Inventor: RYDER HAMISH
IPC: C07D401/06
Filed: 1994-08-26
Abstract: PCT No. PCT/GB93/00404 Sec. 371 Date Sep. 14, 1994 Sec. 102(e) Date Sep. 14, 1994 PCT Filed Feb. 26, 1993 PCT Pub. No. WO93/16999 PCT Pub. Date Sep. 2, 1993This invention relates to benzodiazepine derivatives which are useful as drugs exhibiting antagonism at the gastrin and/or CCK-B receptor, and to their production.
Patent FI-945434-A0 (FI)
Inventor: FLYNN GARY ALAN
IPC: A61P43/00
Filed: 1994-11-18
Abstract: The present invention relates to novel mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase.
Patent FI-946104-A0 (FI)
Inventor: EIBL JOHANN
IPC: A61K39/395
Filed: 1994-12-27
Abstract: A stable, highly concentrated immunoglobulin preparation which is intravenously tolerated and has an immunoglobulin content of 13.5 to 17.5 % (W/V), an osmolarity of 250 to 600 mOs/l and a viscosity not exceeding 9 Cp is described. The immunoglobulin preparation has excellent stability and can, because of its low viscosity even as highly concentrated preparation, be used intravenously without problems.
Patent FI-954351-A0 (FI)
Inventor: GRIMMIN MICHAEL JOHN
IPC: A61P43/00
Filed: 1995-09-15
Abstract: PCT No. PCT/GB94/00495 Sec. 371 Date Dec. 1, 1995 Sec. 102(e) Date Dec. 1, 1995 PCT Filed Mar. 14, 1994 PCT Pub. No. WO94/21625 PCT Pub. Date Sep. 29, 1994Compounds of general formula (I) wherein R1 represents a hydrogen atom or a C1-C6 alkyl, C1-C6 alkenyl, phenyl, phenyl(C1-C6)alkyl, C1-C6 alkylthiomethyl, phenylthiomethyl, substituted phenylthiomethyl, phenyl(C1-C6)alkylthiomethyl or heterocyclylthiomethyl group; or R1 represents -S-Rx wherein Rx represents a group  alpha ; R2 represents a hydrogen atom or a C1-C6 alkyl, C1-C6 alkenyl, phenyl(C1-C6)alkyl, cycloalkyl(C1-C6)alkyl, or cycloalkenyl(C1-C6)alkyl; R3 represents an amino acid side chain or a C1-C6 alkyl, benzyl, (C1-C6)alkoxybenzyl, benzyloxy(C1-C6)alkyl or benzyloxybenzyl group; R4 represents a hydrogen atom or a methyl group; R5 represents a group (CH2)nA; or R4 and R5 together represent a group  beta ; Q represents CH2 or CO; m is an integer from 1 to 3; n is an integer from 1 to 6; and A represents a hydroxy, (C1-C6)alkoxy, (C2-C7)acyloxy, (C1-C6)alkylthio, phenylthio, (C2-C7)acylamino or N-pyrrolidone group or a salt and/or N-oxide and/or (where the compound is a thio-compound) a sulphoxide or sulphone thereof have collagenase inhibition activity and are useful in the management of disease involving tissue degradation and/or the promotion of wound healing. Diseases involving tissue degradation include arthropathy (particularly rheumatoid arthritis), inflammation, dermatological diseases, bone resorption diseases and tumour invasion.
Patent FI-955097-A0 (FI)
Inventor: BOTTLINGER MICHAEL
IPC: B01F25/62
Filed: 1995-10-26
Abstract: A process for mixing a pumpable fluid comprising finely divided solid particles having an average particle size of less than 1mm and a liquid suitable for a food or drink which comprises feeding the pumpable fluid through an inlet (25) into a mixing chamber (22) bounded by first and second facing walls and a peripheral side wall, the first and second walls being formed by a pair of spaced discs (19,11) with their opposing faces parallel, the first disc being a stationary disc and the second disc being a rotary disc adapted to rotate about its longitudinal axis, each disc being provided with spikes (12) extending transversely from their opposing faces within the space between the discs, the spikes from the stationary disc being disposed in interdigital relationship with the spikes from the rotary disc, rotating the rotary disc to mix the pumpable fluid and removing the mixed pumpable fluid from the mixing chamber through an outlet positioned centrifugally of the inlet. <IMAGE>
Patent FI-960480-A0 (FI)
Inventor: HUHTALA RAIMO
IPC: F16K3/03
Filed: 1996-02-02
Abstract: The present invention relates to a flow rate control element for ducts, said control element operating based on the iris-diaphragm principle and including an annular housing comprised of a base part (3) with a cover part (4) made to fit thereon, and said housing having therein adapted essentially curved leaves (7), which are pivotally connected at their one ends to said housing, and further including a control ring having radial slots made thereto in which slots the other ends of the leaves are adapted to move, whereby said leaves are made steplessly rotatable between their closed and open positions by turning the control ring. The invention is implemented by forming for each leaf (7) to be installed in one part of the housing, advantageously the base part (3), a nonpenetrating indent or outdent, respectively, whereby to that side of the leaf to be installed facing said indented or outdented side is formed an essentially complementarily shaped outdent or indent, whereby the pivotal cooperation of the outdent/indent pair permits unobstructed rotation of the leaf (7) about its pivot point.
Patent FI-960977-A0 (FI)
Inventor: MASURE ROBERT H
IPC: A61K39/00
Filed: 1996-03-01
Abstract: PCT No. PCT/US94/09942 Sec. 371 Date Apr. 10, 1996 Sec. 102(e) Date Apr. 10, 1996 PCT Filed Sep. 1, 1994 PCT Pub. No. WO95/06732 PCT Pub. Date Mar. 9, 1995Provided herein are novel nucleic acids which encode exported proteins of Gram positive bacteria, and the proteins encoded by such nucleic acids. Also provided are methods of producing such exported proteins, and vaccines for protecting an animal from infection with a gram positive bacterium, wherein the vaccines utilize the novel nucleic acids and proteins of the invention.
Patent FI-970971-A0 (FI)
Inventor: PETTERSSON HAOKAN
IPC: B66B5/04
Filed: 1997-03-07
Abstract: PCT No. PCT/FI98/00206 Sec. 371 Date Jan. 6, 1999 Sec. 102(e) Date Jan. 6, 1999 PCT Filed Mar. 6, 1998 PCT Pub. No. WO98/40304 PCT Pub. Date Sep. 17, 1998The invention relates to a procedure and an apparatus intended to be used in elevator installation to install the overspeed governor (28) for the time it takes to install the elevator. According to the invention, when the elevator is being installed, at least one suspension element (17) is fastened to the upper part of the elevator shaft (2), an element (30) supporting the overspeed governor (28) is fitted to the suspension element and the position of the overspeed governor (28) at least in the vertical direction is so adjusted that it corresponds to the final placement of the overspeed governor (28). After the elevator guide rails (56) have been installed, the overspeed governor is removed from the suspension element (17) and fixed to a guide rail.
Patent FI-972671-A0 (FI)
Inventor: LONGUEVILLE JACQUES
IPC: H01R13/6586
Filed: 1997-06-19
Abstract: PCT No. PCT/EP95/05046 Sec. 371 Date Oct. 21, 1997 Sec. 102(e) Date Oct. 21, 1997 PCT Filed Dec. 20, 1995 PCT Pub. No. WO96/19850 PCT Pub. Date Jun. 27, 1996The printed circuit board connector element has a plurality of signal contacts (2) arranged grid-like in a spring clip (1) and a shielding unit (3) that contains a first and second ground lamina (4, 5) that are conductively connected via a bridge (6) that have a first impressible ground terminal (7) projecting from it. The ground laminae (4, 5) respectively extend over all intervening signal contacts (2) of a column, whereby a shielding unit is provided for only every second signal contact column. As a result thereof, only one signal contact per two columns need be occupied with ground or, respectively, only one shielding unit per two columns is required for the complete shielding of all columns.
Patent IL-72512-A0 (IL)
Title: Crystal suspensions of insulin derivatives,processes for their preparation and their use
IPC: A61K38/28
Filed: 1984-07-26
Abstract: 1. Claims (for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE) Process for the preparation of suspensions of uniformly shaped crystals having a substantially homogeneous size distribution, in particular prisms about 10 mu m in size, of one or more insulin derivatives of the formula I   see diagramm : EP0133285,P10,F1   in which R**1 denotes H or H-Phe, R**30 represents the residue of a neutral, genetically encodable L-amino acid and R**31 represents a physiologically tolerated organic group which is basic in character and has up to 50 C atoms, and in whose structure 0 to 3 alpha-amino acids and involved, and whose terminal carboxyl group, which is present where appropriate, can be in the free form, or in the form of an ester group, an amide group, a lactone or reduced to CH2 OH, having an isoelectric point between 5.8 and 8.5, characterized in that the crystallization is carried out in an aqueous medium in the neighbourhood of the isoelectric point of the derivative(s) in the presence of glycerol as tonicizing agent and at least one phenol. 1. Claims (for the Contracting State AT) Process for the preparation of suspensions of uniformly shaped crystals having a substantially homogeneous size distribution, in particular prisms about 10 mu m in size, of one or more insulin derivatives of the formula I   see diagramm : EP0133285,P11,F1   in which R**1 denotes H or H-Phe, R**30 represents the residue of a neutral, genetically endocable L-amino acid and R**31 represents a physiologically tolerated organic group which is basic in character and has up to 50 C atoms, and in whose structure 0 to 3 alpha-amino acids are involved, and whose terminal carboxyl group, which is present where appropriate, can be in the free form, or in the form of an ester group, an amide group, a lactone or reduced to CH2 OH, having an isoelectric point between 5.8 and 8.5, characterized in that the crystallization is carried out in an aqueous medium in the neighbourhood of the isoelectric point of the derivative(s) in the presence of glycerol as tonicizing agent and at least one phenol.
Patent IL-83759-A0 (IL)
Title: Method for heat sealing thermoplastic membranes
IPC: B29C65/10
Filed: 1987-09-02
Abstract: A method for heat sealing a portion of an upper heat sealable thermoplastic membrane (10) to a portion of a lower heat sealable thermoplastic membrane (12) which comprises placing a detachable stabilizer strip (20) on the outer surface of the upper membrane over the over-lap seam portions to be sealed. The stabilizer strip (20) must fully adhere or have mechanical contact to retain the dimensional stability of the upper membrane while maintaining the relative positions of the membranes. A hot air medium is directed between the upper and lower membranes thereby effecting a heat seal therebetween. Once the overlapped and sealed portions of the membranes are permitted to cool, the stabilizer strip may be removed.
Patent IL-90259-A0 (IL)
Title: Platinum-polymer complexes and their use as antitumor agents
IPC: C08F8/44
Filed: 1989-05-11
Abstract: Platinum(amine) complexes, when covalently linked to a water-soluble, biodegradable or biostable polymer, exhibit high antitumor activity at low dosages of platinum against L1210 and solid tumors. The complexes are platinum square planar complexes and octahedral structures of the formulae  <IMAGE>  wherein A2 represents either 2 ammonia ligands, 2 monodentate amine ligands or a single bidentate amine ligand; P is either a biodegradable or a biostable but biocompatible polymer having pendent anionic groups which form covalent linkages with Pt; o is a positive integer and X is an anionic ligand.
Patent IL-92838-A0 (IL)
Title: Agrobacteria containing a dna sequence and potatoes containing said dna sequence
IPC: C12N9/14
Filed: 1989-12-21
Abstract: A DNA sequence of an expression cassette on which the potato tuber-specific regulatory regions are located, and the transfer of this DNA sequence into the plant genome using Agrobacteria as transfer microorganisms are described. The DNA sequence contains a patatin gene with a patatin gene promoter. The transferred DNA sequence ensures both regulation of endogenous and production of heterologous products in crop plants.
Patent IL-99536-A0 (IL)
Title: Isoprenoid phospholipase a2 inhibitors and pharmaceutical preparations comprising them
IPC: A61K31/203
Filed: 1991-09-20
Abstract: Compounds of the formula <CHEM>  wherein R1 is    CH=CY-C(CH3)=CHX       wherein X and Y are different and each is of the formula <CHEM> wherein R' and R'' independently are H or alkyl of C1-6 and R1 includes all possible geometric isomers. are demonstrated effective in treating inflammation, both topically and internally. The mechanism appears to be the inhibition of phospholipase A2 enzymes.
Patent FI-20021039-A0 (FI)
Inventor: MIETTINEN OSMO
IPC: H01F17/06
Filed: 2002-05-31
Abstract: The invention relates to a fastening device for fastening a toroidal choking coil (1) to a base or the like, the toroidal choking coil comprising an inner circumference defined by a surface parallel with an axis of rotation of the toroidal choking coil and located closest to the axis of rotation. The toroidal choking coil further comprises an outer circumference defined by a surface parallel with the axis of rotation of the toroidal choking coil and located outermost from the axis of rotation, and side surfaces defined by surfaces perpendicular to the axis of rotation of the toroidal choking coil and connecting the inner circumference and the outer circumference. The fastening device for a toroidal choking coil of the invention comprises at least one pair of choking coil fasteners (3) consisting of a first choking coil fastener (3a) and a second choking coil fastener (3b), arranged to be installed on opposite side surfaces of the toroidal choking coil (1), and that at least one choking coil fastener (3a, 3b) is arranged to come at least partly into contact with the outer circumference of the toroidal choking coil (1) and at least one choking coil fastener (3a, 3b) is arranged to come at least partly into contact with the inner circumference of the toroidal choking coil (1). <IMAGE>
Patent IL-100478-A0 (IL)
Title: Process for preparation of(6s)and(6r)-tetrahydrofolic acid
IPC: C07D475/04
Filed: 1991-12-23
Abstract: The invention relates to a process for the preparation of (6S)- and (6R)-tetrahydrofolic acid and the addition salts thereof with a sulphonic acid or with sulphuric acid, which is characterised in that (6R,S)-tetrahydrofolic acid is reacted with a sulphonic acid or with sulphuric acid, resulting acid addition salt is fractionally crystallised and, if desired, the (6S)- or (6R)-tetrahydrofolic acid is liberated from the resulting diastereomeric acid addition salts by treatment with a base and isolated. The invention additionally relates to the novel acid addition salts of (6S)- and (6R)-tetrahydrofolic acid with a sulphonic acid or with sulphuric acid, to their use as a medicament or starting material for the production of a medicament and to their use for the preparation of optically active 5-methyl-, 5-formyl- and 5,10-methylenetetrahydrofolic acids and the salts thereof with strong bases and acids.
Patent IL-101206-A0 (IL)
Title: Benzo-fused lactams,their preparation and pharmaceutical compositions containing them
IPC: A61P43/00
Filed: 1992-03-12
Abstract: There are disclosed certain novel compounds identified as benzo-fused lactams which promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to increase the stature of those afflicted with a lack of a normal secretion of natural growth hormone. Growth promoting compositiors containing such benzo-fused lactams as the active ingredient thereof are also disclosed.
Patent IL-110294-A0 (IL)
Title: MDR reversal agents
IPC: C07C323/56
Filed: 1994-07-12
Abstract: Compounds of the general formula: <CHEM> wherein R1, R2, R3, R4 and R5 are herein described, A is a straight or branched (C2-C12)alkyl or a phenyl moiety and B is a moiety of the formula: <CHEM> The compounds are effective in potentiating the activity of chemotherapeutic anti-cancer agents by increasing the sensitivity of multi-drug resistant cells to such chemotherapeutic agents.
Patent IL-120696-A0 (IL)
Title: Component B as cicatrizant
IPC: A61P17/00
Filed: 1997-04-17
Abstract: PCT No. PCT/EP96/01702 Sec. 371 Date Jan. 27, 1999 Sec. 102(e) Date Jan. 27, 1999 PCT Filed Apr. 24, 1996 PCT Pub. No. WO97/39765 PCT Pub. Date Oct. 30, 1997The present invention relates to the use of Component B as cicatrizant, in particular in the treatment of wounds, ulcers and other traumatic lesions to any of the tissues in the body.
Patent IL-122408-A0 (IL)
Title: Dna encoding a trail polypeptide and its preparation
IPC: C07K16/28
Filed: 1996-06-25
Abstract: A novel cytokine designated TRAIL induces apoptosis of certain target cells, including cancer cells and virally infected cells. Isolated DNA sequences encoding TRAIL are disclosed, along with expression vectors and transformed host cells useful in producing TRAIL polypeptides. Antibodies that specifically bind TRAIL are provided as well.
Patent IL-133214-A0 (IL)
Title: Fermentation process for the preparation of d-pantothenic acid by amplifying the pand gene in microorganisms
IPC: C12N15/52
Filed: 1999-11-30
Abstract: Recombinant DNA (I), comprising a nucleotide sequence (Ia) encoding aspartate-1-decarboxylase, present in microorganisms, especially Corynebacterium and Escherichia, is new. Independent claims are also included for the following: (1) microorganisms (II), especially of the genus Corynebacterium or Escherichia, transformed with (I); (2) plasmid vector pND-D2 (III) deposited as Corynebacterium glutamicum ATCC 13032/pND-D2 under DSM 12438; (3) plasmid vector pND-DBC2 (IV) deposited as Corynebacterium glutamicum ATCC 13032/pND-DBC2 under DSM 12437; and (4) a method (V) for the preparation of D-pantothenic acid, comprising overexpressing (Ia) in (II) and performing fermentation.
Patent IL-157407-A0 (IL)
Title: Forming a mark on a gemstone or industrial diamond
IPC: A44C17/00
Filed: 2002-02-18
Abstract: To form a micro mark on the table (7a) of a diamond (7), a holder or dop (11) with the diamond (7) is spun, a photo resist is applied to the table (7a), the resist is baked by heating the base of the dop (11), and the dop (11) is transferred to the table (30) of apparatus for exposing the resist. The resist is exposed using an exposure radiation with a pattern which is a reduced image of a mask (35), working through an objective lens (38). The exposure radiation is projected by a radiation source (31) and can be 350 to 450 nm. In order to locate, orientate and focus the image, the radiation source (31) is arranged to project light in the wavelength range 500 to 550 nm, which does not affect the resist, forming a setting-up image on the table (7a), the setting-up image is viewed in an observation plane (44) through the objective lens (38) and a beam splitter (36). After exposure, the resist is developed and the exposed area of the table (7a) is then milled using a plasma.
Patent IL-164943-A0 (IL)
Title: An improved cleaning system
IPC: F28G1/12
Filed: 2003-03-28
Abstract: A cleaning system for cleaning tubing using cleaning balls ( 20 ) circulated with the fluid through tubing ( 8 ). The system includes a separator ( 12 ) having a perforated funnel, which permits the fluid, but not the cleaning balls ( 20 ), to pass through. A housing ( 21 ) having an apertured partition ( 28 ) is used to divide the housing ( 21 ) into an first compartment ( 19 ) and a second compartment ( 27 ). An entrance ( 2 ) of a fluid supply pipe ( 23 ) and an exit ( 3 ) of a ball supply pipe ( 24 ) are formed for creating a difference in pressure to create a suction force to recirculate the cleaning balls ( 20 ) from the housing ( 21 ) via the ball supply pipe ( 24 ), back to the tubing ( 8 ) for cleaning the walls of the tubing ( 8 ). An entrance ( 13 ) of a ball return pipe ( 17 ) and an exit ( 14 ) of a fluid return pipe ( 16 ) are formed for creating a difference in pressure to create a suction force to recirculate the cleaning balls ( 20 ) from the separator ( 12 ) via the ball return pipe ( 17 ), into the housing ( 21 ).
Patent IL-193064-A0 (IL)
Title: Metal complexes
IPC: C07C29/17
Filed: 2008-07-24
Abstract: Compounds of the formulae (I) and (Ia) where X<SUB>1 </SUB>is secondary phosphino; R<SUB>3 </SUB>is a hydrocarbon radical having from 1 to 20 C atoms, a heterohydrocarbon radical which has from 2 to 20 atoms and at least one heteroatorn selected from the group consisting of O, S, NH and NR, or an -SO<SUB>2</SUB>-R radical; R is C<SUB>1</SUB>-C<SUB>18</SUB>-alkyl, phenyl or benzyl; the radicals R<SUB>4 </SUB>are each, or the two radicals R4 together a hydrocarbon radical having from 1 to 20 C atoms; R<SUB>01 </SUB>is a hydrocarbon radical having from 1 to 20 C atoms; and R<SUB>02 </SUB>and R'<SUB>o2 </SUB>are each, independently of one another, a hydrogen atom or independently have the meaning of R<SUB>01</SUB>, or R<SUB>01 </SUB>and R<SUB>02 </SUB>together with the C atom to which they are bound form a three- to eight-membered hydrocarbon or hetero hydrocarbon ring. The compounds are chiral ligands for complexes of metals of transition groups I and VIII which act as catalysts for asymmetric additions, for example of hydrogen, onto prochiral unsaturated organic compounds.
Patent IL-201735-A0 (IL)
Title: Therapeutic compounds
Filed: 2009-10-25
Abstract: A (+)-stereoisomer of formula (I), wherein X is H or F; or a salt thereof; which is useful: as an anesthetic; for inducing or maintaining general anesthesia; for promoting sedation; for promoting an antiemetic effect; for treatment of nausea or vomiting; or for treatment of a migraine.
Patent RO-129495-A0 (RO)
Title: Channel for cables and pipes
Inventor: ZAHIU LAURENŢIU VALENTIN
IPC: H02G3/04
Filed: 2013-12-03
Abstract: The invention relates to a channel for cables and pipes or for any type of flexible or rigid elements which need to be supported, guided and protected against accidental damage or destruction, such as electric power cables, communication or IT cables or flexible or rigid pipes for conveying gaseous or liquid products. According to the invention, the channel comprises some linear assemblies () which may be coupled to one another and also with some T-shaped assemblies () and some cross-shaped assemblies (), where the linear assemblies () are made of some longitudinal profiles () and some connecting cross members (), the longitudinal profiles () having a base plate () and a vertical wall () provided in its medial region with some inclined longitudinal zones () having the role of stiffening rib, in the opposite part of the base plate () there being also two plates (), namely a horizontal plate and an inclined longitudinal plate, respectively, having the role of stiffening rib.